XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
146 hedge funds and large institutions have $826M invested in Acceleron Pharma in 2016 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 54 increasing their positions, 37 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
30% less capital invested
Capital invested by funds: $1.18B → $826M (-$357M)
70% less call options, than puts
Call options by funds: $579K | Put options by funds: $1.93M
Holders
146
Holding in Top 10
3
Calls
$579K
Puts
$1.93M
Top Buyers
| 1 | +$19.7M | |
| 2 | +$13.7M | |
| 3 | +$11M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$9.45M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$9.39M |
Top Sellers
| 1 | -$17M | |
| 2 | -$12.4M | |
| 3 | -$11.5M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.1M |
| 5 |
Goldman Sachs
New York
|
-$9.23M |